Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia
NCT00111371
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Dyslexia
Interventions
DRUG:
Levodopa
Sponsor
University Hospital Muenster